| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024 | 1 | GlobeNewswire (USA) | ||
| Mi | Soleno Therapeutics to Participate in Upcoming Investor Conferences | 1 | GlobeNewswire (USA) | ||
| 15.05. | Soleno Therapeutics Stands with the Prader-Willi Syndrome Community | 1 | GlobeNewswire (USA) | ||
| 09.05. | Soleno Therapeutics GAAP EPS of -$0.59 misses by $0.22 | 3 | Seeking Alpha | ||
| 09.05. | SOLENO THERAPEUTICS INC - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.05. | SOLENO THERAPEUTICS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 03.05. | Soleno Therapeutics announces pricing of $138M public offering | 1 | Seeking Alpha | ||
| 03.05. | Soleno Therapeutics Prices Public Offering Of 3 Mln Shares At $46/shr; Stock Down In After-hours | 1 | RTTNews | ||
| 03.05. | Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock | 1 | GlobeNewswire (USA) | ||
| 02.05. | Soleno Therapeutics announces proposed common stock offering | 1 | Seeking Alpha | ||
| 02.05. | Soleno Therapeutics Announces Proposed Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| 29.04. | Why Soleno Therapeutics Stock Is Skyrocketing Today | 7 | The Motley Fool | ||
| 29.04. | Soleno Therapeutics receives breakthrough therapy designation from FDA for PWS treatment | 8 | Seeking Alpha | ||
| 22.04. | SOLENO THERAPEUTICS INC - 8-K, Current Report | 3 | SEC Filings | ||
| 19.04. | Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 66 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment... ► Artikel lesen | |
| 08.03. | Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 66 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment... ► Artikel lesen | |
| 07.03. | SOLENO THERAPEUTICS INC - 8-K, Current Report | 3 | SEC Filings | ||
| 07.03. | SOLENO THERAPEUTICS INC - 10-K, Annual Report | - | SEC Filings | ||
| 06.03. | Soleno Therapeutics GAAP EPS of -$0.33 misses by $0.07 | 2 | Seeking Alpha | ||
| 06.03. | Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results | 82 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment... ► Artikel lesen |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 727 |
| EVOTEC | 536 |
| NEL | 451 |
| TUI | 422 |
| GAMESTOP | 343 |
| BAYER | 338 |
| BIONTECH | 306 |
| PLUG POWER | 261 |
| RHEINMETALL | 213 |
| TESLA | 209 |
| BYD | 203 |
| DEUTSCHE LUFTHANSA | 199 |
| VOLKSWAGEN | 175 |
| SUPER MICRO COMPUTER | 172 |
| DEUTSCHE BANK | 166 |
| SIEMENS ENERGY | 166 |
| COMMERZBANK | 152 |
| AMD | 141 |
| MERCEDES-BENZ | 135 |
| BASF | 127 |
| THYSSENKRUPP | 127 |
| RWE | 126 |
| AIXTRON SE | 124 |
| PAYPAL | 119 |
| MICROSOFT | 111 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
